David Eric Crump

David Eric Crump is a notable inventor based in Balwyn North, Australia. He has made significant contributions to the field of medicine, particularly in the treatment of pulmonary diseases. With a total of 2 patents, Crump's work focuses on innovative methods to improve patient outcomes.

Latest Patents

Crump's latest patents include a method of treating pulmonary disease by administering an antibody to G-CSF. This invention relates to a method for treating or preventing the effects of pulmonary diseases characterized by neutrophil infiltration and associated complications. The invention also provides agents and pharmaceutical compositions that inhibit the activity of G-CSF or its receptor, interfere with G-CSF signaling, and down-regulate the expression of G-CSF or its receptor. Another patent by Crump is a method of treating pulmonary disease by administering an antibody to the G-CSF receptor, which shares similar objectives and applications as his first patent.

Career Highlights

Crump has established himself as a key figure in the medical research community. His work has the potential to significantly impact the treatment of pulmonary diseases, offering new avenues for therapeutic intervention.

Collaborations

Crump collaborates with Andrew Donald Nash, further enhancing the innovative efforts in their field.

Conclusion

David Eric Crump's contributions to pulmonary disease treatment through his patents demonstrate his commitment to advancing medical science. His innovative methods hold promise for improving the lives of patients suffering from these conditions.

Profile summary based on public USPTO records.